CVS Health Corp (CVS) : Farr Miller Washingtondc reduced its stake in CVS Health Corp by 1.62% during the most recent quarter end. The investment management company now holds a total of 392,658 shares of CVS Health Corp which is valued at $40.7 Million after selling 6,449 shares in CVS Health Corp , the firm said in a disclosure report filed with the SEC on May 12, 2016.CVS Health Corp makes up approximately 4.76% of Farr Miller Washingtondc’s portfolio.
Other Hedge Funds, Including , Guardian Life Insurance Co Of America reduced its stake in CVS by selling 1,150 shares or 21.92% in the most recent quarter. The Hedge Fund company now holds 4,096 shares of CVS which is valued at $424,632. CVS Health Corp makes up approx 0.08% of Guardian Life Insurance Co Of America’s portfolio. Numeric Investors sold out all of its stake in CVS during the most recent quarter. The investment firm sold 22,300 shares of CVS which is valued $2.3 Million.Tdam Usa reduced its stake in CVS by selling 106,662 shares or 65.04% in the most recent quarter. The Hedge Fund company now holds 57,325 shares of CVS which is valued at $6 Million. CVS Health Corp makes up approx 0.29% of Tdam Usa’s portfolio.Swiss National Bank boosted its stake in CVS in the latest quarter, The investment management firm added 848,500 additional shares and now holds a total of 2,972,610 shares of CVS Health Corp which is valued at $311.7 Million. CVS Health Corp makes up approx 0.55% of Swiss National Bank’s portfolio.Eads Heald Investment Counsel reduced its stake in CVS by selling 343 shares or 2.3% in the most recent quarter. The Hedge Fund company now holds 14,593 shares of CVS which is valued at $1.5 Million. CVS Health Corp makes up approx 1.02% of Eads Heald Investment Counsel’s portfolio.
CVS Health Corp closed down -1.49 points or -1.48% at $99.46 with 1,05,25,511 shares getting traded on Friday. Post opening the session at $101.36, the shares hit an intraday low of $99.08 and an intraday high of $101.36 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
On the company’s financial health, CVS Health Corp reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on May 3, 2016. Analyst had a consensus of $1.16. The company had revenue of $43215.00 million for the quarter, compared to analysts expectations of $43000.77 million. The company’s revenue was up 18.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS.
Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Mizuho on May 4, 2016 to “Buy”, Firm has raised the Price Target to $ 117 from a previous price target of $104 .Company shares were Reiterated by RBC Capital Mkts on May 4, 2016 to “Outperform”, Firm has raised the Price Target to $ 115 from a previous price target of $110 .Company shares were Reiterated by Barclays on Mar 10, 2016 to “Overweight”, Firm has raised the Price Target to $ 115 from a previous price target of $110 .
CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.